{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:52:44Z","timestamp":1790977964513,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03546-9","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:54:57Z","timestamp":1790974497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glutamine-tagged Sorafenib and Atorvastatin Coloaded Polymeric Nanoparticles for Hybrid Cell Death Induction in Colorectal Cancer: Part I Formulation, Characterization, In-vitro\/In-vivo Safety and Efficacy Evaluation"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8957-8875","authenticated-orcid":false,"given":"Vivek","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6375-1256","authenticated-orcid":false,"given":"Sayali","family":"Dighe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5435-8807","authenticated-orcid":false,"given":"Pratik","family":"Dhake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-9563","authenticated-orcid":false,"given":"Sanyog","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"12","key":"3546_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","volume":"25","author":"KB Kennel","year":"2025","unstructured":"Kennel KB, Greten FR. The immune microenvironment of colorectal cancer. Nat Rev Cancer. 2025;25(12):945\u201364. https:\/\/doi.org\/10.1038\/s41568-025-00872-1.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"3546_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tcb.2022.11.003","volume":"33","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Johnson CH. Targeting ferroptosis to treat colorectal cancer. Trends Cell Biol. 2023;33(3):185\u20138. https:\/\/doi.org\/10.1016\/j.tcb.2022.11.003.","journal-title":"Trends Cell Biol"},{"key":"3546_CR3","doi-asserted-by":"publisher","first-page":"123570","DOI":"10.1016\/j.ijpharm.2023.123570","volume":"648","author":"R Ghadi","year":"2023","unstructured":"Ghadi R, Pandey PK, Gabhale A, Wadikar A, Dharshini M, Kuche K, et al. Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer. Int J Pharm. 2023;648:123570. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123570.","journal-title":"Int J Pharm"},{"issue":"8","key":"3546_CR4","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41416-023-02149-6","volume":"128","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Aladelokun O, Bosenberg M, Johnson CH. Ferroptosis in colorectal cancer: a future target? Br J Cancer. 2023;128(8):1439\u201351. https:\/\/doi.org\/10.1038\/s41416-023-02149-6.","journal-title":"Br J Cancer"},{"issue":"15","key":"3546_CR5","doi-asserted-by":"publisher","first-page":"1462505","DOI":"10.3389\/fimmu.2024.1462505","volume":"18","author":"Y Li","year":"2024","unstructured":"Li Y, Bi Y, Li W, Piao Y, Piao J, Wang T, et al. Research progress on ferroptosis in colorectal cancer. Front Immunol. 2024;18(15):1462505. https:\/\/doi.org\/10.3389\/fimmu.2024.1462505.","journal-title":"Front Immunol"},{"key":"3546_CR6","doi-asserted-by":"publisher","first-page":"105450","DOI":"10.1016\/j.ejps.2020.105450","volume":"152","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y, et al. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Eur J Pharm Sci. 2020;152:105450. https:\/\/doi.org\/10.1016\/j.ejps.2020.105450.","journal-title":"Eur J Pharm Sci"},{"key":"3546_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.freeradbiomed.2023.09.014","volume":"208","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Li L, Chen H, Zheng Y, Tan X, Zhang G, et al. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression. Free Radical Biol Med. 2023;208:530\u201344. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.09.014.","journal-title":"Free Radical Biol Med"},{"issue":"11","key":"3546_CR8","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.7150\/thno.44705","volume":"10","author":"P Chen","year":"2020","unstructured":"Chen P, Li X, Zhang R, Liu S, Xiang Y, Zhang M, et al. Combinative treatment of \u03b2-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 2020;10(11):5107\u201319. https:\/\/doi.org\/10.7150\/thno.44705.","journal-title":"Theranostics"},{"key":"3546_CR9","doi-asserted-by":"publisher","first-page":"175913","DOI":"10.1016\/j.ejphar.2023.175913","volume":"955","author":"Q Li","year":"2023","unstructured":"Li Q, Chen K, Zhang T, Jiang D, Chen L, Jiang J, et al. Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy. Eur J Pharmacol. 2023;955:175913. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175913.","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"3546_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jons.2016.07.008","volume":"2","author":"T Kacan","year":"2016","unstructured":"Kacan T, Nayir E, Altun A, Kilickap S, Babacan NA, Ataseven H, et al. Antitumor activity of sorafenib on colorectal cancer. J Oncol Sci. 2016;2(2\u20133):53\u20137. https:\/\/doi.org\/10.1016\/j.jons.2016.07.008.","journal-title":"J Oncol Sci"},{"key":"3546_CR11","doi-asserted-by":"publisher","first-page":"127254","DOI":"10.1016\/j.ijbiomac.2023.127254","volume":"253","author":"K Kuche","year":"2023","unstructured":"Kuche K, Yadav V, Dharshini M, Ghadi R, Chaudhari D, Date T, et al. Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin. Int J Biol Macromol. 2023;253:127254. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127254.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3546_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1208\/s12249-025-03304-3","volume":"27","author":"D Patel","year":"2025","unstructured":"Patel D, Bhardwaj S, Yadav V, Kuche K, Dhake P, Jain S. Exploring the co-delivery of sorafenib and venetoclax to induce ferroptosis and apoptosis mediated cancer cell death using surface modified PLGA nanoparticles. AAPS PharmSciTech. 2025;27(1):58. https:\/\/doi.org\/10.1208\/s12249-025-03304-3.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3546_CR13","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1007\/s13277-015-3249-x","volume":"36","author":"O Fiala","year":"2015","unstructured":"Fiala O, Pesek M, Finek J, Minarik M, Benesova L, Bortlicek Z, et al. Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation. Tumor Biol. 2015;36(8):5801\u20135. https:\/\/doi.org\/10.1007\/s13277-015-3249-x.","journal-title":"Tumor Biol"},{"issue":"7","key":"3546_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1208\/s12249-023-02639-z","volume":"24","author":"K Kuche","year":"2023","unstructured":"Kuche K, Yadav V, Patel M, Ghadi R, Jain S. Exploring sorafenib and simvastatin combination for ferroptosis-induced cancer treatment: cytotoxicity screening, in vivo efficacy, and safety assessment. AAPS PharmSciTech. 2023;24(7):180. https:\/\/doi.org\/10.1208\/s12249-023-02639-z.","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"3546_CR15","doi-asserted-by":"publisher","first-page":"806081","DOI":"10.3389\/fcell.2022.806081","volume":"3","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Qu H, Chen Y, Luo X, Chen C, Xiao B, et al. Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT\/GPx4 axis. Front Cell Dev Biol. 2022;3(10):806081. https:\/\/doi.org\/10.3389\/fcell.2022.806081.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"3546_CR16","doi-asserted-by":"publisher","first-page":"e002474","DOI":"10.1136\/jitc-2021-002474","volume":"9","author":"GH Nam","year":"2021","unstructured":"Nam GH, Kwon M, Jung H, Ko E, Kim SA, Choi Y, et al. Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer. J Immunother Cancer. 2021;9(7):e002474. https:\/\/doi.org\/10.1136\/jitc-2021-002474.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"3546_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1208\/s12249-026-03461-z","volume":"27","author":"V Yadav","year":"2026","unstructured":"Yadav V, Dighe S, Dhake P, Jain S. Exploring synergistic potential of sorafenib and atorvastatin to launch apoptosis and ferroptosis-driven mixed cell death mechanism in colorectal cancer. AAPS PharmSciTech. 2026;27(5):221. https:\/\/doi.org\/10.1208\/s12249-026-03461-z.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"3546_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","volume":"63","author":"S Acharya","year":"2011","unstructured":"Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63(3):170\u201383. https:\/\/doi.org\/10.1016\/j.addr.2010.10.008.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"3546_CR19","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s13346-022-01273-9","volume":"13","author":"D Chaudhari","year":"2023","unstructured":"Chaudhari D, Kuche K, Yadav V, Ghadi R, Date T, Bhargavi N, et al. Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer. Drug Deliv and Transl Res. 2023;13(4):1074\u201387. https:\/\/doi.org\/10.1007\/s13346-022-01273-9.","journal-title":"Drug Deliv and Transl Res"},{"issue":"10","key":"3546_CR20","doi-asserted-by":"publisher","first-page":"104478","DOI":"10.1016\/j.drudis.2025.104478","volume":"30","author":"S Dighe","year":"2025","unstructured":"Dighe S, Manchanda N, Sharma S, Jain S. Nutrient-transporter driven cytotoxic potential: an emerging nanotherapeutic approach. Drug Discovery Today. 2025;30(10):104478. https:\/\/doi.org\/10.1016\/j.drudis.2025.104478.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"3546_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12967-026-07733-x","volume":"24","author":"Q Qin","year":"2026","unstructured":"Qin Q, Zhang D, Xie Y, Zhang F, Huang Y, Deng R, et al. Glutamine-driven upregulation of NPDC1 promotes colorectal cancer progression through PI3K\/AKT signaling. J Transl Med. 2026;24(1):268. https:\/\/doi.org\/10.1186\/s12967-026-07733-x.","journal-title":"J Transl Med"},{"key":"3546_CR22","doi-asserted-by":"publisher","first-page":"213822","DOI":"10.1016\/j.bioadv.2024.213822","volume":"159","author":"R Ghadi","year":"2024","unstructured":"Ghadi R, Kuche K, Date T, Nallamothu B, Chaudhari D, Jain S. Unlocking apoptosis in triple negative breast cancer: Harnessing \u201cglutamine trap\u201d to amplify the efficacy of lapatinib-loaded mixed micelles. Biomater Adv. 2024;159:213822. https:\/\/doi.org\/10.1016\/j.bioadv.2024.213822.","journal-title":"Biomater Adv"},{"key":"3546_CR23","doi-asserted-by":"publisher","first-page":"213700","DOI":"10.1016\/j.bioadv.2023.213700","volume":"156","author":"K Kuche","year":"2024","unstructured":"Kuche K, Yadav V, Patel M, Chaudhari D, Date T, Jain S. Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy. Biomaterials Advances. 2024;156:213700. https:\/\/doi.org\/10.1016\/j.bioadv.2023.213700.","journal-title":"Biomaterials Advances"},{"issue":"4","key":"3546_CR24","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.carbpol.2011.07.012","volume":"86","author":"SF Chin","year":"2011","unstructured":"Chin SF, Pang SC, Tay SH. Size controlled synthesis of starch nanoparticles by a simple nanoprecipitation method. Carbohyd Polym. 2011;86(4):1817\u20139. https:\/\/doi.org\/10.1016\/j.carbpol.2011.07.012.","journal-title":"Carbohyd Polym"},{"issue":"6","key":"3546_CR25","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1021\/acsbiomaterials.1c01582","volume":"8","author":"T Date","year":"2022","unstructured":"Date T, Kuche K, Chaudhari D, Ghadi R, Sahel DK, Chitkara D, et al. Hitting multiple cellular targets in triple-negative breast cancer using dual-action cisplatin (IV) prodrugs for safer synergistic chemotherapy. ACS Biomater Sci Eng. 2022;8(6):2349\u201362.","journal-title":"ACS Biomater Sci Eng"},{"key":"3546_CR26","doi-asserted-by":"publisher","first-page":"111664","DOI":"10.1016\/j.msec.2020.111664","volume":"120","author":"R Swami","year":"2021","unstructured":"Swami R, Kumar Y, Chaudhari D, Katiyar SS, Kuche K, Katare PB, et al. pH sensitive liposomes assisted specific and improved breast cancer therapy using co-delivery of SIRT1 shRNA and docetaxel. Mater Sci Eng C Mater Biol Appl. 2021;120:111664. https:\/\/doi.org\/10.1016\/j.msec.2020.111664.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"8","key":"3546_CR27","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1021\/acsbiomaterials.2c00594","volume":"8","author":"D Chaudhari","year":"2022","unstructured":"Chaudhari D, Katari O, Ghadi R, Kuche K, Date T, Bhargavi N, et al. Unfolding the potency of adenosine in targeting triple negative breast cancer via paclitaxel-incorporated pH-responsive stealth liposomes. ACS Biomater Sci Eng. 2022;8(8):3473\u201384. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c00594.","journal-title":"ACS Biomater Sci Eng"},{"issue":"7","key":"3546_CR28","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1021\/acs.molpharmaceut.0c00211","volume":"17","author":"M Bathara","year":"2020","unstructured":"Bathara M, Date T, Chaudhari D, Ghadi R, Kuche K, Jain S. Exploring the promising potential of high permeation vesicle-mediated localized transdermal delivery of docetaxel in breast cancer to overcome the limitations of systemic chemotherapy. Mol Pharm. 2020;17(7):2473\u201386.","journal-title":"Mol Pharm"},{"key":"3546_CR29","doi-asserted-by":"publisher","first-page":"134138","DOI":"10.1016\/j.colsurfa.2024.134138","volume":"693","author":"R Ghadi","year":"2024","unstructured":"Ghadi R, Gabhale A, Pandey PK, Muley A, Kuche K, Yadav V, et al. Biotin-stapled mixed micelles of lapatinib: unleashing apoptosis power in triple-negative breast cancer. Colloids Surf A Physicochem Eng Asp. 2024;693:134138. https:\/\/doi.org\/10.1016\/j.colsurfa.2024.134138.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"3546_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-019-4587-1","author":"S \u0141ukasiewicz","year":"2019","unstructured":"\u0141ukasiewicz S, Miko\u0142ajczyk A, Szcz\u0119ch M, Szczepanowicz K, Warszy\u0144ski P, Dziedzicka-Wasylewska M. Encapsulation of clozapine into polycaprolactone nanoparticles as a promising strategy of the novel nanoformulation of the active compound. J Nanopart Res. 2019. https:\/\/doi.org\/10.1007\/s11051-019-4587-1.","journal-title":"J Nanopart Res"},{"key":"3546_CR31","doi-asserted-by":"publisher","first-page":"123879","DOI":"10.1016\/j.ijpharm.2024.123879","volume":"653","author":"F Bayat","year":"2024","unstructured":"Bayat F, Dadashzadeh S, Aboofazeli R, Torshabi M, Baghi AH, Tamiji Z, et al. Oral delivery of posaconazole-loaded phospholipid-based nanoformulation: preparation and optimization using design of experiments, machine learning, and TOPSIS. Int J Pharm. 2024;653:123879. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123879.","journal-title":"Int J Pharm"},{"issue":"1","key":"3546_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.15171\/apb.2018.010","volume":"8","author":"F Madani","year":"2018","unstructured":"Madani F, Esnaashari SS, Mujokoro B, Dorkoosh F, Khosravani M, Adabi M. Investigation of effective parameters on size of paclitaxel loaded PLGA nanoparticles. Adv Pharm Bull. 2018;8(1):77\u201384. https:\/\/doi.org\/10.15171\/apb.2018.010.","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"3546_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijpharm.2006.11.061","volume":"336","author":"A Budhian","year":"2007","unstructured":"Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int J Pharm. 2007;336(2):367\u201375. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.11.061.","journal-title":"Int J Pharm"},{"issue":"8","key":"3546_CR34","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1080\/21691401.2016.1276924","volume":"45","author":"A Sahin","year":"2017","unstructured":"Sahin A, Esendagli G, Yerlikaya F, Caban-Toktas S, Yoyen-Ermis D, Horzum U, et al. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles\u2019 characteristics and efficacy of intracellular delivery. Artif Cells Nanomed Biotechnol. 2017;45(8):1657\u201364. https:\/\/doi.org\/10.1080\/21691401.2016.1276924.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3546_CR35","doi-asserted-by":"publisher","first-page":"109950","DOI":"10.1016\/j.msec.2019.109950","volume":"104","author":"P Rafiei","year":"2019","unstructured":"Rafiei P, Haddadi A. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery. Mater Sci Eng, C. 2019;104:109950. https:\/\/doi.org\/10.1016\/j.msec.2019.109950.","journal-title":"Mater Sci Eng, C"},{"issue":"1s","key":"3546_CR36","doi-asserted-by":"publisher","first-page":"s135","DOI":"10.5530\/ijper.55.1s.44","volume":"55","author":"SG Kala","year":"2021","unstructured":"Kala SG, Chinni S. Development of raloxifene hydrochloride loaded mPEG-PLA nanoparticles for oral delivery. IJPER. 2021;55(1s):s135\u201348. https:\/\/doi.org\/10.5530\/ijper.55.1s.44.","journal-title":"IJPER"},{"issue":"1","key":"3546_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1477-3155-10-38","volume":"10","author":"AP Ranjan","year":"2012","unstructured":"Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK. Scale up, optimization and stability analysis of curcumin C3 complex-loaded nanoparticles for cancer therapy. J Nanobiotechnol. 2012;10(1):38. https:\/\/doi.org\/10.1186\/1477-3155-10-38.","journal-title":"J Nanobiotechnol"},{"issue":"1\u20136","key":"3546_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12645-012-0027-y","volume":"3","author":"S Pimple","year":"2012","unstructured":"Pimple S, Manjappa AS, Ukawala M, Murthy RSR. PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy. Cancer Nano. 2012;3(1\u20136):25\u201336. https:\/\/doi.org\/10.1007\/s12645-012-0027-y.","journal-title":"Cancer Nano"},{"key":"3546_CR39","unstructured":"Koopaei MN, Khoshayand MR, Mostafavi SH, Amini M, Khorramizadeh MR, Tehrani MJ, et al. Docetaxel Loaded PEG-PLGA nanoparticles: Optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect. 2014."},{"key":"3546_CR40","doi-asserted-by":"publisher","first-page":"110915","DOI":"10.1016\/j.msec.2020.110915","volume":"112","author":"B Dutta","year":"2020","unstructured":"Dutta B, Nema A, Shetake NG, Gupta J, Barick KC, Lawande MA, et al. Glutamic acid-coated Fe3O4 nanoparticles for tumor-targeted imaging and therapeutics. Mater Sci Eng C Mater Biol Appl. 2020;112:110915. https:\/\/doi.org\/10.1016\/j.msec.2020.110915.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"3546_CR41","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02988-3","volume":"26","author":"L Bhute","year":"2024","unstructured":"Bhute L, Dighe S, Katari O, Yadav V, Jain S. Bifunctional Oxaliplatin (IV) prodrug based pH-sensitive PEGylated liposomes for synergistic anticancer action against triple negative breast cancer. AAPS PharmSciTech. 2024;26(1):2. https:\/\/doi.org\/10.1208\/s12249-024-02988-3.","journal-title":"AAPS PharmSciTech"},{"issue":"16","key":"3546_CR42","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.2217\/nnm.13.225","volume":"9","author":"H Harde","year":"2014","unstructured":"Harde H, Agrawal AK, Jain S. Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery. Nanomedicine (Lond). 2014;9(16):2511\u201329. https:\/\/doi.org\/10.2217\/nnm.13.225.","journal-title":"Nanomedicine (Lond)"},{"key":"3546_CR43","doi-asserted-by":"publisher","first-page":"112880","DOI":"10.1016\/j.colsurfb.2022.112880","volume":"220","author":"I Youm","year":"2022","unstructured":"Youm I, West MB, Huang X, Li W, Kopke RD. Enhanced sucrose-mediated cryoprotection of siRNA-loaded poly (lactic-co-glycolic acid) nanoparticles. Colloids Surf, B. 2022;220:112880. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112880.","journal-title":"Colloids Surf, B"},{"issue":"7","key":"3546_CR44","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/02652040500273753","volume":"22","author":"A Budhian","year":"2005","unstructured":"Budhian A, Siegel SJ, Winey KI. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol. J Microencapsul. 2005;22(7):773\u201385. https:\/\/doi.org\/10.1080\/02652040500273753.","journal-title":"J Microencapsul"},{"issue":"4","key":"3546_CR45","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/jps.21158","volume":"97","author":"DK Sahana","year":"2008","unstructured":"Sahana DK, Mittal G, Bhardwaj V, Kumar MNVR. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci. 2008;97(4):1530\u201342. https:\/\/doi.org\/10.1002\/jps.21158.","journal-title":"J Pharm Sci"},{"issue":"12","key":"3546_CR46","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/cnma.202000528","volume":"6","author":"N Soomherun","year":"2020","unstructured":"Soomherun N, Kreua-ongarjnukool N, Niyomthai ST, Chumnanvej S. Kinetics of drug release via nicardipine hydrochloride-loaded carboxymethyl cellulose\/Poly(D,L-lactic-co-glycolic acid) nanocarriers using a contemporary emulsion process. ChemNanoMat. 2020;6(12):1754\u201369. https:\/\/doi.org\/10.1002\/cnma.202000528.","journal-title":"ChemNanoMat"},{"issue":"11","key":"3546_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11051-018-4387-z","volume":"20","author":"LMDAC Gaspar","year":"2018","unstructured":"Gaspar LMDAC, D\u00f3rea ACS, Droppa-Almeida D, De M\u00e9lo Silva IS, Montoro FE, Alves LL, et al. Development and characterization of PLGA nanoparticles containing antibiotics. J Nanopart Res. 2018;20(11):289. https:\/\/doi.org\/10.1007\/s11051-018-4387-z.","journal-title":"J Nanopart Res"},{"issue":"4","key":"3546_CR48","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1159\/000341465","volume":"30","author":"A Lupescu","year":"2012","unstructured":"Lupescu A, Shaik N, Jilani K, Zelenak C, Lang E, Pasham V, et al. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem. 2012;30(4):876\u201388. https:\/\/doi.org\/10.1159\/000341465.","journal-title":"Cell Physiol Biochem"},{"key":"3546_CR49","doi-asserted-by":"crossref","unstructured":"Miotto G. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. 2020.","DOI":"10.1016\/j.redox.2019.101328"},{"key":"3546_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"LJ Su","year":"2019","unstructured":"Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019;2019:1\u201313. https:\/\/doi.org\/10.1155\/2019\/5080843.","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"3546_CR51","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1158\/1535-7163.MCT-12-0093","volume":"11","author":"R Coriat","year":"2012","unstructured":"Coriat R, Nicco C, Ch\u00e9reau C, Mir O, Alexandre J, Ropert S, et al. Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo. Mol Cancer Ther. 2012;11(10):2284\u201393. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0093.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"3546_CR52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1089\/ars.2014.6190","volume":"24","author":"J Bouitbir","year":"2016","unstructured":"Bouitbir J, Singh F, Charles AL, Schlagowski AI, Bonifacio A, Echaniz-Laguna A, et al. Statins trigger mitochondrial reactive oxygen species-induced apoptosis in glycolytic skeletal muscle. Antioxid Redox Signal. 2016;24(2):84\u201398. https:\/\/doi.org\/10.1089\/ars.2014.6190.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"3546_CR53","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.3892\/mmr.2017.7558","volume":"16","author":"H Lan","year":"2017","unstructured":"Lan H, Yuan H, Lin C. Sulforaphane induces p53-deficient SW480 cell apoptosis via the ROS-MAPK signaling pathway. Mol Med Rep. 2017;16(5):7796\u2013804. https:\/\/doi.org\/10.3892\/mmr.2017.7558.","journal-title":"Mol Med Rep"},{"key":"3546_CR54","unstructured":"Ferroptosis triggers mitochondrial fragmentation via Drp1 activation | Cell Death & Disease. Cell Death."},{"issue":"36","key":"3546_CR55","doi-asserted-by":"publisher","first-page":"15105","DOI":"10.1074\/jbc.M117.783175","volume":"292","author":"C Zhang","year":"2017","unstructured":"Zhang C, Liu Z, Bunker E, Ramirez A, Lee S, Peng Y, et al. Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1\u2013Parkin pathway and modulate cellular drug response. J Biol Chem. 2017;292(36):15105\u201320. https:\/\/doi.org\/10.1074\/jbc.M117.783175.","journal-title":"J Biol Chem"},{"issue":"3","key":"3546_CR56","doi-asserted-by":"publisher","first-page":"867","DOI":"10.31557\/APJCP.2022.23.3.867","volume":"23","author":"R Abolghasemi","year":"2022","unstructured":"Abolghasemi R, Ebrahimi-Barough S, Bahrami N, Ai J. Atorvastatin inhibits viability and migration of MCF7 breast cancer cells. Asian Pac J Cancer Prev. 2022;23(3):867\u201375. https:\/\/doi.org\/10.31557\/APJCP.2022.23.3.867.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"35","key":"3546_CR57","doi-asserted-by":"publisher","first-page":"37066","DOI":"10.18632\/oncotarget.5797","volume":"6","author":"P Kharaziha","year":"2015","unstructured":"Kharaziha P, Chioureas D, Baltatzis G, Fonseca P, Rodriguez P, Gogvadze V, et al. Sorafenib-induced defective autophagy promotes cell death by necroptosis. Oncotarget. 2015;6(35):37066\u201382. https:\/\/doi.org\/10.18632\/oncotarget.5797.","journal-title":"Oncotarget"},{"issue":"1","key":"3546_CR58","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41598-020-57707-2","volume":"10","author":"A Otahal","year":"2020","unstructured":"Otahal A, Aydemir D, Tomasich E, Minichsdorfer C. Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines. Sci Rep. 2020;10(1):959. https:\/\/doi.org\/10.1038\/s41598-020-57707-2.","journal-title":"Sci Rep"},{"issue":"1","key":"3546_CR59","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1038\/s41467-023-41852-z","volume":"14","author":"Z Ding","year":"2023","unstructured":"Ding Z, Pan Y, Shang T, Jiang T, Lin Y, Yang C, et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat Commun. 2023;14(1):6269. https:\/\/doi.org\/10.1038\/s41467-023-41852-z.","journal-title":"Nat Commun"},{"issue":"12","key":"3546_CR60","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.neo.2017.10.005","volume":"19","author":"S Hao","year":"2017","unstructured":"Hao S, Yu J, He W, Huang Q, Zhao Y, Liang B, et al. Cysteine dioxygenase 1 mediates erastin-induced ferroptosis in human gastric cancer cells. Neoplasia. 2017;19(12):1022\u201332. https:\/\/doi.org\/10.1016\/j.neo.2017.10.005.","journal-title":"Neoplasia"},{"issue":"2","key":"3546_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3892\/ol.2022.13186","volume":"23","author":"P Xu","year":"2022","unstructured":"Xu P, Wang Y, Deng Z, Tan Z, Pei X. MicroRNA-15a promotes prostate cancer cell ferroptosis by inhibiting GPX4 expression. Oncol Lett. 2022;23(2):67. https:\/\/doi.org\/10.3892\/ol.2022.13186.","journal-title":"Oncol Lett"},{"issue":"2","key":"3546_CR62","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"Z Li","year":"2021","unstructured":"Li Z, Dai H, Huang X, Feng J, Deng J, Wang Z, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301\u201310. https:\/\/doi.org\/10.1038\/s41401-020-0478-3.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"3546_CR63","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41420-023-01613-9","volume":"9","author":"X Zhang","year":"2023","unstructured":"Zhang X, Hou L, Guo Z, Wang G, Xu J, Zheng Z, et al. Lipid peroxidation in osteoarthritis: focusing on 4-hydroxynonenal, malondialdehyde, and ferroptosis. Cell Death Discov. 2023;9(1):320. https:\/\/doi.org\/10.1038\/s41420-023-01613-9.","journal-title":"Cell Death Discov"},{"issue":"2\u20133","key":"3546_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0169-409X(95)00024-2","volume":"16","author":"SM Moghimi","year":"1995","unstructured":"Moghimi SM. Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block co-polymers. Adv Drug Deliv Rev. 1995;16(2\u20133):183\u201393. https:\/\/doi.org\/10.1016\/0169-409X(95)00024-2.","journal-title":"Adv Drug Deliv Rev"},{"key":"3546_CR65","doi-asserted-by":"publisher","first-page":"139011","DOI":"10.1016\/j.jcis.2025.139011","volume":"703","author":"C Fan","year":"2026","unstructured":"Fan C, Mei Y, Liu H, Chen L, Li Z, Wu K, et al. Sorafenib (SOR)\/simvastatin (SIM) dual-drug self-assembled nanoparticles for synergistic induction of tumor ferroptosis. J Colloid Interface Sci. 2026;703:139011. https:\/\/doi.org\/10.1016\/j.jcis.2025.139011.","journal-title":"J Colloid Interface Sci"},{"issue":"14","key":"3546_CR66","doi-asserted-by":"publisher","first-page":"23265","DOI":"10.18632\/oncotarget.15575","volume":"8","author":"Y Cheng","year":"2017","unstructured":"Cheng Y, Luo R, Zheng H, Wang B, Liu Y, Liu D, et al. Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma. Oncotarget. 2017;8(14):23265\u201376. https:\/\/doi.org\/10.18632\/oncotarget.15575.","journal-title":"Oncotarget"},{"key":"3546_CR67","doi-asserted-by":"publisher","first-page":"110842","DOI":"10.1016\/j.matdes.2022.110842","volume":"220","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang HY, Jiang Z, Cui YL, Wang QS. Targeted glutamine-decorated chitosan nanoparticles with enhanced synergism of chemotherapeutic and natural medicine for hepatic carcinoma therapy. Mater Des. 2022;220:110842. https:\/\/doi.org\/10.1016\/j.matdes.2022.110842.","journal-title":"Mater Des"},{"key":"3546_CR68","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/DDDT.S443107","volume":"18","author":"J Li","year":"2024","unstructured":"Li J, Zhang L, Ge T, Liu J, Wang C, Yu Q. Understanding sorafenib-induced cardiovascular toxicity: Mechanisms and treatment implications. DDDT. 2024;18:829\u201343. https:\/\/doi.org\/10.2147\/DDDT.S443107.","journal-title":"DDDT"},{"key":"3546_CR69","doi-asserted-by":"publisher","first-page":"122196","DOI":"10.1016\/j.carbpol.2024.122196","volume":"338","author":"R Sharma","year":"2024","unstructured":"Sharma R, Yadav V, Jha S, Dighe S, Jain S. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer. Carbohyd Polym. 2024;338:122196. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122196.","journal-title":"Carbohyd Polym"},{"issue":"2","key":"3546_CR70","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.toxlet.2011.10.023","volume":"208","author":"ST Ahmad","year":"2012","unstructured":"Ahmad ST, Arjumand W, Nafees S, Seth A, Ali N, Rashid S, et al. Hesperidin alleviates acetaminophen induced toxicity in wistar rats by abrogation of oxidative stress, apoptosis and inflammation. Toxicol Lett. 2012;208(2):149\u201361. https:\/\/doi.org\/10.1016\/j.toxlet.2011.10.023.","journal-title":"Toxicol Lett"},{"issue":"5","key":"3546_CR71","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1159\/000430165","volume":"36","author":"E Hochhauser","year":"2015","unstructured":"Hochhauser E, Lahat E, Sultan M, Pappo O, Waldman M, Sarne Y, et al. ultra low dose delta 9-tetrahydrocannabinol protects mouse liver from ischemia reperfusion injury. Cell Physiol Biochem. 2015;36(5):1971\u201381. https:\/\/doi.org\/10.1159\/000430165.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"3546_CR72","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/livers3020022","volume":"3","author":"MR McGill","year":"2023","unstructured":"McGill MR, Kaufmann Y, LoBianco FV, Schleiff MA, Aykin-Burns N, Miller GP. The role of cytochrome P450 3A4-mediated metabolism in sorafenib and lapatinib hepatotoxicity. Livers. 2023;3(2):310\u201321. https:\/\/doi.org\/10.3390\/livers3020022.","journal-title":"Livers"},{"key":"3546_CR73","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.12659\/MSM.915790","volume":"25","author":"H Zeng","year":"2019","unstructured":"Zeng H, Liu Z. Atorvastatin induces hepatotoxicity in diabetic rats via oxidative stress, inflammation, and anti-apoptotic pathway. Med Sci Monit. 2019;25:6165\u201373. https:\/\/doi.org\/10.12659\/MSM.915790.","journal-title":"Med Sci Monit"},{"issue":"2","key":"3546_CR74","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/bcpt.13318","volume":"126","author":"W Ma","year":"2020","unstructured":"Ma W, Liu M, Liang F, Zhao L, Gao C, Jiang X, et al. Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis. Basic Clin Pharma Tox. 2020;126(2):166\u201380. https:\/\/doi.org\/10.1111\/bcpt.13318.","journal-title":"Basic Clin Pharma Tox"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03546-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03546-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03546-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:54:59Z","timestamp":1790974499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03546-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":74,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3546"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03546-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"25 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known financial or personal interests that could have influenced the scientific work presented in this manuscript in any way.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"322"}}